Back to trial details

Intake questionnaire

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Applying to Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville) · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumors?
3. Are you able to travel to Nashville for study visits?